AZB & Partners Advised SCHOTT Pharma On TPG’s 35% Stake Acquisition In SCHOTT Poonawalla From Serum Institute
AZB & Partners advised SCHOTT Pharma on TPG Scion Unit Trust’s acquisition of a 35% stake in SCHOTT Poonawalla from Serum Institute of India, reinforcing its pharmaceutical packaging leadership.
AZB & Partners advised SCHOTT Pharma on TPG’s 35% stake acquisition in SCHOTT Poonawalla from Serum Institute
AZB & Partners advised SCHOTT Pharma in connection with TPG Scion Unit Trust’s acquisition of a 35% stake in SCHOTT Poonawalla Private Limited from Serum Institute of India Private Limited (SII).
SCHOTT Poonawalla is a joint venture between SCHOTT Pharma and SII, part of the Cyrus Poonawalla Group, and focuses on manufacturing high-quality pharmaceutical packaging.
The AZB & Partners team was led by Daksh Trivedi (Senior Partner) and Aman Jain (Partner), with support from Sarthak Sharma (Associate) and Srishti Kaushal (Associate). On competition law aspects, the team was led by Hemangini Dadwal (Senior Partner).
Click to know more about AZB & Partners
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.